Gotfried MH - Search Results

1

Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.

Gotfried MH. Gotfried MH. Expert Rev Anti Infect Ther. 2003 Jun;1(1):9-20. doi: 10.1586/14787210.1.1.9. Expert Rev Anti Infect Ther. 2003. PMID: 15482099 Review.

2

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.

Gotfried M, Notario G, Spiller J, Palmer R, Busman T. Gotfried M, et al. Curr Med Res Opin. 2005 Feb;21(2):245-54. doi: 10.1185/030079905X26243. Curr Med Res Opin. 2005. PMID: 15801995 Clinical Trial.

3

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.

Gotfried M, Busman TA, Norris S, Notario GF. Gotfried M, et al. Curr Med Res Opin. 2007 Feb;23(2):459-66. doi: 10.1185/030079906X162827. Curr Med Res Opin. 2007. PMID: 17288699 Clinical Trial.

4

A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.

Gotfried MH, Dattani D, Riffer E, Devcich KJ, Busman TA, Notario GF, Palmer RN. Gotfried MH, et al. Clin Ther. 2002 May;24(5):736-51. doi: 10.1016/s0149-2918(02)85148-7. Clin Ther. 2002. PMID: 12075942 Clinical Trial.

5

Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.

Gotfried MH, Danziger LH, Rodvold KA. Gotfried MH, et al. J Antimicrob Chemother. 2003 Sep;52(3):450-6. doi: 10.1093/jac/dkg355. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888589 Clinical Trial.

6

Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance.

Gotfried MH. Gotfried MH. Clin Ther. 2000 Jan;22(1):2-14. doi: 10.1016/s0149-2918(00)87973-4. Clin Ther. 2000. PMID: 10688386 Review.

7

Short-course fluoroquinolones in acute exacerbations of chronic bronchitis.

Gotfried MH, Grossman RF. Gotfried MH, et al. Expert Rev Respir Med. 2010 Oct;4(5):661-72. doi: 10.1586/ers.10.52. Expert Rev Respir Med. 2010. PMID: 20923343 Review.

8

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis.

Gotfried MH, DeAbate CA, Fogarty C, Mathew CP, Sokol WN. Gotfried MH, et al. Clin Ther. 2001 Jan;23(1):97-107. doi: 10.1016/s0149-2918(01)80033-3. Clin Ther. 2001. PMID: 11219483 Clinical Trial.

9

Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study.

Gotfried M, Quinn TC, Gothelf S, Wikler MA, Webb CD, Nicholson SC. Gotfried M, et al. Diagn Microbiol Infect Dis. 2002 Sep;44(1):85-91. doi: 10.1016/s0732-8893(02)00447-9. Diagn Microbiol Infect Dis. 2002. PMID: 12376037 Clinical Trial.

10

Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program.

Gotfried MH. Gotfried MH. Am J Med. 2001 Dec 17;111 Suppl 9A:25S-29S; discussion 36S-38S. doi: 10.1016/s0002-9343(01)01028-2. Am J Med. 2001. PMID: 11755440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters